In the context of Alzheimer’s disease, the Akt pathway plays a fundamental role as one of the most potent inhibitors of GSK3, the main kinase that drives tau phosphorylation [151,181]. The gene discussed is AKT1; the disease is early-onset autosomal dominant Alzheimer disease.